Analyst Consensus ?
ConsensusBuy44 ratings
Bullish2352.3%
Neutral2045.4%
Bearish12.3%
FN2 Earnings Intelligence
Incyte Corporation analyst ratings
Incyte Corporation (INCY) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$116.87Current
$48Low
$111.61Average
$200High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 21, 2026 |
| Truist Securities | Hold | Hold | Maintain | Oct 14, 2026 |
| HC Wainwright & Co. | Buy | Buy | Maintain | Oct 13, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 8, 2026 |
| Stifel | Buy | Buy | Maintain | Oct 5, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 1, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Sep 28, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 17, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Aug 4, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Aug 3, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 29, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 29, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 23, 2026 |
| UBS | Neutral | Neutral | Maintain | Jun 26, 2026 |
| Oppenheimer | Perform | Perform | Maintain | Apr 29, 2026 |
| Jefferies | Hold | Buy | Downgrade | Mar 16, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Mar 5, 2026 |
| B of A Securities | Buy | Buy | Maintain | Sep 4, 2025 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2025 |
| William Blair | Market Perform | Outperform | Downgrade | Mar 18, 2025 |
| Citizens Capital Markets | Market Perform | Market Perform | Maintain | Mar 11, 2025 |
| JMP Securities | Market Perform | Market Perform | Maintain | Feb 11, 2025 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jan 10, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 30, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 1, 2024 |
| SVB Leerink | Underperform | Underperform | Maintain | Mar 20, 2023 |
| Credit Suisse | Buy | Buy | Maintain | Feb 16, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 8, 2023 |
| Benchmark | Buy | Hold | Upgrade | Jul 20, 2021 |
| Guggenheim Securities | Neutral | Buy | Downgrade | Jan 2, 2020 |
| Nomura | Buy | Buy | Maintain | Jul 31, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Apr 11, 2019 |
| Argus Research | Buy | Buy | Maintain | Feb 25, 2019 |
| Argus | Buy | Buy | Maintain | Feb 25, 2019 |
| Gabelli & Co. | Buy | Hold | Upgrade | Jan 24, 2019 |
| Leerink Swann | Perform | Market Perform | Maintain | Sep 25, 2018 |
| Raymond James | Outperform | Market Perform | Upgrade | Sep 11, 2017 |
| PiperJaffray | Neutral | Overweight | Downgrade | Apr 17, 2017 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Aug 5, 2016 |
| Brean Capital | Buy | Buy | Maintain | Feb 12, 2016 |
| Bank of America | Buy | Buy | Maintain | May 29, 2015 |
| Lazard | Buy | Neutral | Upgrade | Jan 14, 2013 |
| Canaccord Genuity | Buy | Buy | Maintain | Apr 26, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $116.87. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Oppenheimer | Analyst unavailable | $152 | $113.31 | +30.1% | Oct 27, 2026 |
| Raymond James | Analyst unavailable | $152 | $113.27 | +30.1% | Oct 16, 2026 |
| Truist Financial | Srikripa Devarakonda | $115 | $111.44 | -1.6% | Oct 14, 2026 |
| RBC Capital | Analyst unavailable | $114 | $111.78 | -2.5% | Oct 8, 2026 |
| UBS | Ashwani Verma | $127 | $113.03 | +8.7% | Oct 5, 2026 |
| Stifel Nicolaus | Stephen Willey | $157 | $115.3 | +34.3% | Oct 5, 2026 |
| H.C. Wainwright | Mitchell Kapoor | $152 | $123.89 | +30.1% | Sep 28, 2026 |
| Canaccord Genuity | Analyst unavailable | $152 | $128.47 | +30.1% | Aug 20, 2026 |
| Piper Sandler | Allison Bratzel | $130 | $120.16 | +11.2% | Aug 17, 2026 |
| Bernstein | Analyst unavailable | $104 | $120.77 | -11.0% | Aug 13, 2026 |
| Leerink Partners | Andrew Berens | $155 | $119.52 | +32.6% | Aug 3, 2026 |
| RBC Capital | Brian Abrahams | $109 | $126.69 | -6.7% | Jul 29, 2026 |
| BMO Capital | Analyst unavailable | $130 | $128.83 | +11.2% | Jul 29, 2026 |
| Guggenheim | Whitney Ljem | $150 | $129.93 | +28.3% | Jul 29, 2026 |
| Morgan Stanley | Analyst unavailable | $119 | $129.93 | +1.8% | Jul 29, 2026 |
| H.C. Wainwright | Analyst unavailable | $150 | $129.93 | +28.3% | Jul 29, 2026 |
| Barclays | Analyst unavailable | $139 | $129.93 | +18.9% | Jul 29, 2026 |
| Stifel Nicolaus | Stephen Willey | $145 | $130.08 | +24.1% | Jul 28, 2026 |
| Oppenheimer | Analyst unavailable | $120 | $130.08 | +2.7% | Jul 28, 2026 |
| Morgan Stanley | Analyst unavailable | $104 | $116.12 | -11.0% | Jul 23, 2026 |
| Barclays | Analyst unavailable | $134 | $114.23 | +14.7% | Jul 14, 2026 |
| BMO Capital | Analyst unavailable | $112 | $115.04 | -4.2% | Jul 13, 2026 |
| RBC Capital | Analyst unavailable | $99 | $115.62 | -15.3% | Jul 7, 2026 |
| UBS | Analyst unavailable | $113 | $107.53 | -3.3% | Jun 26, 2026 |
| Truist Financial | Analyst unavailable | $105 | $103.21 | -10.2% | Jun 22, 2026 |
| BMO Capital | Evan David Seigerman | $94 | $98.22 | -19.6% | Jun 22, 2026 |
| H.C. Wainwright | Mitchell Kapoor | $140 | $103.23 | +19.8% | Jun 10, 2026 |
| Stifel Nicolaus | Stephen Willey | $123 | $103.07 | +5.2% | Jun 9, 2026 |
| Oppenheimer | Jay Olson | $107 | $100.64 | -8.4% | Jun 8, 2026 |
| Bernstein | Analyst unavailable | $99 | $97.41 | -15.3% | May 21, 2026 |
| Oppenheimer | Analyst unavailable | $90 | $97.74 | -23.0% | Apr 29, 2026 |
| Barclays | Analyst unavailable | $117 | $101.16 | +0.1% | Feb 18, 2026 |
| Morgan Stanley | Analyst unavailable | $102 | $98.45 | -12.7% | Feb 11, 2026 |
| Stifel Nicolaus | Stephen Willey | $120 | $100.05 | +2.7% | Feb 11, 2026 |
| Piper Sandler | Allison Bratzel | $110 | $102.76 | -5.9% | Feb 6, 2026 |
| H.C. Wainwright | Analyst unavailable | $135 | $102.6 | +15.5% | Feb 5, 2026 |
| Barclays | Analyst unavailable | $116 | $100.92 | -0.7% | Feb 4, 2026 |
| Wells Fargo | Analyst unavailable | $107 | $106.21 | -8.4% | Jan 20, 2026 |
| Goldman Sachs | Analyst unavailable | $90 | $110.57 | -23.0% | Jan 8, 2026 |
| Stifel Nicolaus | Stephen Willey | $119 | $101.79 | +1.8% | Jan 5, 2026 |
| Truist Financial | Srikripa Devarakonda | $103 | $100.91 | -11.9% | Dec 24, 2025 |
| Morgan Stanley | Analyst unavailable | $92 | $96.46 | -21.3% | Dec 8, 2025 |
| Wells Fargo | Derek Archila | $116 | $102.52 | -0.7% | Dec 8, 2025 |
| Mizuho Securities | Salim Syed | $121 | $102.52 | +3.5% | Dec 8, 2025 |
| Barclays | Analyst unavailable | $115 | $102.06 | -1.6% | Nov 24, 2025 |
| Piper Sandler | Allison Bratzel | $102 | $102.35 | -12.7% | Nov 4, 2025 |
| Truist Financial | Analyst unavailable | $93 | $90.35 | -20.4% | Oct 29, 2025 |
| RBC Capital | Analyst unavailable | $84 | $91.65 | -28.1% | Oct 29, 2025 |
| Wells Fargo | Derek Archila | $97 | $92.02 | -17.0% | Oct 29, 2025 |
| Barclays | Peter Lawson | $101 | $91.65 | -13.6% | Oct 29, 2025 |
| UBS | Analyst unavailable | $68 | $77.55 | -41.8% | Jul 30, 2025 |
| RBC Capital | Analyst unavailable | $67 | $67.26 | -42.7% | Jun 23, 2025 |
| Guggenheim | Analyst unavailable | $92 | $60 | -21.3% | Mar 18, 2025 |
| Seaport Global | Aaron Kessler | $200 | $73 | +71.1% | Oct 30, 2024 |
| Oppenheimer | Jay Olson | $82 | $73.6 | -29.8% | Oct 30, 2024 |
| Citigroup | David Lebowitz | $97 | $73.6 | -17.0% | Oct 30, 2024 |
| Jefferies | Kelly Shi | $84 | $73.6 | -28.1% | Oct 29, 2024 |
| Bank of America Securities | Tazeen Ahmad | $90 | $73.6 | -23.0% | Oct 29, 2024 |
| Wolfe Research | Andy Chen | $84 | $66.1 | -28.1% | Sep 30, 2024 |
| Bank of America Securities | Tazeen Ahmad | $68 | $63.56 | -41.8% | Sep 16, 2024 |
| Goldman Sachs | Salveen Richter | $60 | $63.56 | -48.7% | Sep 16, 2024 |
| Citigroup | David Lebowitz | $92 | $62.16 | -21.3% | Aug 18, 2024 |
| RBC Capital | Brian Abrahams | $66 | $65.7 | -43.5% | Jul 31, 2024 |
| Oppenheimer | Jay Olson | $81 | $68.57 | -30.7% | Jul 26, 2024 |
| BMO Capital | Evan Seigerman | $48 | $60.87 | -58.9% | Jul 2, 2024 |
| Deutsche Bank | James Shin | $55 | $58.2 | -52.9% | May 23, 2024 |
| BMO Capital | Evan David Seigerman | $52 | $52.05 | -55.5% | Apr 30, 2024 |
| Argus Research | Jasper Hellweg | $70 | $50.48 | -40.1% | Apr 25, 2024 |
| Cowen & Co. | Analyst unavailable | $100 | $80.38 | -14.4% | Feb 8, 2023 |
| Wells Fargo | Analyst unavailable | $75 | $79.74 | -35.8% | Jan 3, 2023 |
| Oppenheimer | Jay Olson | $98 | $73.99 | -16.1% | Aug 15, 2022 |
| Leerink Partners | Analyst unavailable | $63 | $81.36 | -46.1% | Jul 20, 2022 |
| Morgan Stanley | Analyst unavailable | $76 | $78.94 | -35.0% | Apr 20, 2022 |
| BMO Capital | Evan Seigerman | $75 | $70.07 | -35.8% | Feb 8, 2022 |
| Guggenheim | Michael Schmidt | $104 | $73.97 | -11.0% | Jan 3, 2022 |
| Goldman Sachs | Salveen Richter | $136 | $66.74 | +16.4% | Nov 24, 2021 |
| Oppenheimer | Jay Olson | $109 | $66.79 | -6.7% | Nov 3, 2021 |
| Cantor Fitzgerald | Alethia Young | $79 | $65.56 | -32.4% | Oct 15, 2021 |
| Ladenburg Thalmann & Co. | Aydin Huseynov | $89 | $69.78 | -23.8% | Sep 23, 2021 |
Track every rating change on INCY the moment it posts. Free to start.
Start freeGet the INCY recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.